EN HU

Csépány Tünde

Csépány Tünde

Publication list

Uploaded publications:
97
Publications in DEA:
94
OA:
27
Date range:
1990-2024
2024
1.
Csépány, T., Rózsa, C., Deme, I., Mike, A., Bencsik, K., Bereczki, D., Bíró, Z., Illés, Z., Jakab, G., Jobbágy, Z., Komoly, S., Lovas, G., Mátyás, K., Rajda, C., Simó, M., Vécsei, L.: A Magyar Neuroimmunológiai Társaság szakmai ajánlása: A sclerosis multiplex diagnosztikájáról és kezeléséről.
Ideggyógy. Szle. Proc. 9 (1), 1-59, 2024.
2.
Spelman, T., Herring, W. L., Acosta, C., Hyde, R., Jokubaitis, V., Pucci, E., Lugaresi, A., Laureys, G., Havrdova, E., Horakova, D., Izquierdo, G., Eichau, S., Ozakbas, S., Alroughani, R., Kalincik, T., Duquette, P., Girard, M., Petersen, T., Patti, F., Csépány, T., Granella, F., Grand'Maison, F., Ferraro, D., Karabudak, R., José Sá, M., Trojano, M., Pesch, V. v., Wijmeersch, B. V., Cartechini, E., McCombe, P., Gerlach, O., Spitaleri, D., Rózsa, C., Hodgkinson, S., Bergamaschi, R., Gouider, R., Soysal, A., Prevost, J., Garber, J., de Gans, K., Ampapa, R., Simó, M., Sanchez-Menoyo, J., Iuliano, G., Sas, A., Walt, A. v. d., John, N., Gray, O., Hughes, S., De Luca, G., Onofrj, M., Buzzard, K., Skibina, O., Terzi, M., Slee, M., Solaro, C., Ramo-Tello, C., Fragoso, Y., Shaygannejad, V., Moore, F., Rajda, C., Aguera-Morales, E., Butzkueven, H.: Comparative effectiveness and cost-effectiveness of natalizumab and fingolimod in rapidly evolving severe relapsing-remitting multiple sclerosis in the United Kingdom.
J Med Econ. 27 (1), 109-125, 2024.
Journal metrics:
Q1 Health Policy
3.
Bicskó, R. R., Illés, Á., Hevessy, Z., Ivády, G., Kerekes, G., Méhes, G., Csépány, T., Gergely, L.: Eculizumab Treatment of Massive Hemolysis Occurring in a Rare Co-Existence of Paroxysmal Nocturnal Hemoglobinuria and Myasthenia Gravis.
Hematol Rep. 16 (2), 255-259, 2024.
Journal metrics:
Q3 Hematology
4.
Li, Y., Saul, A., Taylor, B. V., Ponsonby, A. L., Simpson-Yap, S., Blizzard, L., Broadley, S., Lechner-Scott, J., Karabudak, R., Patti, F., Eichau, S., Onofrj, M., Ozakbas, S., Horakova, D., Kubala Havrdova, E., Grand'Maison, F., Alroughani, R., Gerlach, O., Amato, M. P., Altintas, A., Girard, M., Duquette, P., Blanco, Y., Ramo-Tello, C., Laureys, G., Kalincik, T., Khoury, S. J., Shaygannejad, V., Etemadifar, M., Singhal, B., Mrabet, S., Foschi, M., Habek, M., John, N., Hughes, S., McCombe, P., Ampapa, R., Walt, A. v. d., Butzkueven, H., de Gans, K., McGuigan, C., Oreja-Guevara, C., Sá, M. J., Petersen, T., Al-Harbi, T., Sempere, P. A., Wijmeersch, B. V., Grigoriadis, N., Prevost, J., Gray, O., Castillo Triviño, T., Macdonell, R., Lugaresi, A., Sajedi, S. A., Mei, I. v. d., Ausimmune/AusLong Investigators Group, MSBase Study Group: Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies.
J. Neurol. 271 (1), 472-485, 2024.
5.
De Brouwer, E., Becker, T., Werthen-Brabants, L., Csépány, T., Vella, N., Moreau, Y., Peeters, L.: Machine-learning-based prediction of disability progression in multiple sclerosis: an observational, international, multi-center study.
PLOS Digit Health. 3 (7), 1-25, (article identifier: 0000533), 2024.
6.
De Brouwer, E., Becker, T., Werthen-Brabants, L., Dewulf, P., Iliadis, D., Dekeyser, C., Laureys, G., Wijmeersch, B. V., Popescu, V., Dhaene, T., Deschrijver, D., Waegeman, W., De Baets, B., Stock, M. J., Horakova, D., Patti, F., Izquierdo, G., Eichau, S., Girard, M., Prat, A., Lugaresi, A., Grammond, P., Kalincik, T., Alroughani, R., Grand'Maison, F., Skibina, O., Terzi, M., Lechner-Scott, J., Gerlach, O., Khoury, S. J., Cartechini, E., Pesch, V. v., Sá, M. J., Weinstock-Guttman, B., Blanco, Y., Ampapa, R., Spitaleri, D., Solaro, C., Maimone, D., Soysal, A., Iuliano, G., Gouider, R., Castillo Triviño, T., Sanchez-Menoyo, J., Laureys, G., Walt, A. v. d., Oh, J., Aguera-Morales, E., Altintas, A., Al-Asmi, A., de Gans, K., Fragoso, Y., Csépány, T., Hodgkinson, S., Deri, N., Al-Harbi, T., Taylor, B. V., Gray, O., Lalive, P. H., Rózsa, C., McGuigan, C., Kermode, A. G., Sempere, P. A., Mihaela, S., Simó, M., Hardy, T. A., Decoo, D., Hughes, S., Grigoriadis, N., Sas, A., Vella, N., Moreau, Y., Peeters, L.: Machine-learning-based prediction of disability progression in multiple sclerosis: an observational, international, multi-center study.
PLOS Digit. Health. 3 (7), 1-25, (article identifier: 0000533), 2024.
7.
Siriratnam, P., Sanfilippo, P., Walt, A. v. d., Sharmin, S., Foong, Y. C., Yeh, W. Z., Zhu, C., Khoury, S. J., Csépány, T., Willekens, B., Etemadifar, M., Ozakbas, S., Nytrova, P., Altintas, A., Al-Asmi, A., Yamout, B., Laureys, G., Patti, F., Simó, M., Surcinelli, A., Foschi, M., McCombe, P., Alroughani, R., Sanchez-Menoyo, J., Turkoglu, R., Soysal, A., Lechner Scott, J., Kalincik, T., Butzkueven, H., Jokubaitis, V., Huda, S., Monif, M., MSBase Study Group: Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: a multicentre study.
J. Neurol. Neurosurg. Psychiatry. [Epub ahead of print], (article identifier: 2024), 2024.
Journal metrics:
D1 Neurology (clinical)
D1 Psychiatry and Mental Health
D1 Surgery
8.
Siriratnam, P., Huda, S., Walt, A. v. d., Sanfilippo, P., Sharmin, S., Foong, Y. C., Yeh, W. Z., Zhu, C., Khoury, S. J., Csépány, T., Willekens, B., Etemadifar, M., Ozakbas, S., Nytrova, P., Altintas, A., Al-Asmi, A., Ramo-Tello, C., Laureys, G., Patti, F., Horakova, D., Foschi, M., Boz, C., McCombe, P., Turkoglu, R., Lechner-Scott, J., Roos, I., Kalincik, T., Jokubaitis, V., Butzkueven, H., Monif, M., MSBase Study Group: Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD.
Neurology. 103 (12), 1-8, (article identifier: 209940), 2024.
Journal metrics:
D1 Neurology (clinical)
9.
Dekeyser, C., Hautekeete, M., Cambron, M., Pesch, V. v., Patti, F., Kuhle, J., Khoury, S. J., Lechner Scott, J., Gerlach, O., Lugaresi, A., Maimone, D., Surcinelli, A., Grammond, P., Kalincik, T., Habek, M., Willekens, B., Macdonell, R., Lalive, P. H., Csépány, T., Butzkueven, H., Boz, C., Tomassini, V., Foschi, M., Sanchez-Menoyo, J., Altintas, A., Mrabet, S., Iuliano, G., Sá, M. J., Alroughani, R., Karabudak, R., Aguera-Morales, E., Gray, O., de Gans, K., Walt, A. v. d., McCombe, P., Deri, N., Garber, J., Al-Asmi, A., Skibina, O., Duquette, P., Cartechini, E., Spitaleri, D., Gouider, R., Soysal, A., Van Hijfte, L., Slee, M., Amato, M. P., Buzzard, K., Laureys, G.: Routine CSF parameters as predictors of disease course in multiple sclerosis: an MSBase cohort study.
J. Neurol. Neurosurg. Psychiatry. 95 (11), 1021-1031, 2024.
Journal metrics:
D1 Neurology (clinical)
D1 Psychiatry and Mental Health
D1 Surgery
2023
10.
Roos, I., Diouf, I., Sharmin, S., Horakova, D., Havrdova, E., Patti, F., Shaygannejad, V., Ozakbas, S., Izquierdo, G., Eichau, S., Onofrj, M., Lugaresi, A., Alroughani, R., Prat, A., Girard, M., Duquette, P., Terzi, M., Boz, C., Grand'Maison, F., Sola, P., Ferraro, D., Grammond, P., Turkoglu, R., Buzzard, K., Skibina, O., Yamout, B., Altintas, A., Gerlach, O., Pesch, V. v., Blanco, Y., Maimone, D., Lechner-Scott, J., Bergamaschi, R., Karabudak, R., McGuigan, C., Cartechini, E., Barnett, M., Hughes, S., Sá, M. J., Solaro, C., Ramo-Tello, C., Hodgkinson, S., Spitaleri, D., Soysal, A., Petersen, T., Granella, F., de Gans, K., McCombe, P., Ampapa, R., Wijmeersch, B. V., Walt, A. v. d., Butzkueven, H., Prevost, J., Sanchez-Menoyo, J., Laureys, G., Gouider, R., Castillo Triviño, T., Gray, O., Aguera-Morales, E., Al-Asmi, A., Shaw, C., Deri, N., Al-Harbi, T., Fragoso, Y., Csépány, T., Sempere, P. A., Trevino-Frenk, I., Schepel, J., Moore, F., Malpas, C., Kalincik, T., MSBase Study Group: Comparative effectiveness in multiple sclerosis: A methodological comparison.
Mult. Scler. 29 (3), 326-332, 2023.
Journal metrics:
D1 Neurology
D1 Neurology (clinical)
11.
Kalincik, T., Sharmin, S., Roos, I., Freedman, M. S., Atkins, H., Burman, J., Massey, J., Sutton, I., Withers, B., Macdonell, R., Grigg, A., Torkildsen, ø., Bo, L., Lehmann, A. K., Kubala Havrdova, E., Krasulova, E., Trneny, M., Kozak, T., Walt, A. v. d., Butzkueven, H., McCombe, P., Skibina, O., Lechner-Scott, J., Willekens, B., Cartechini, E., Ozakbas, S., Alroughani, R., Kuhle, J., Patti, F., Duquette, P., Lugaresi, A., Khoury, S. J., Slee, M., Turkoglu, R., Hodgkinson, S., John, N., Maimone, D., José Sá, M., Pesch, V. v., Gerlach, O., Laureys, G., Van Hijfte, L., Karabudak, R., Spitaleri, D., Csépány, T., Gouider, R., Castillo Triviño, T., Taylor, B. V., Sharrack, B., Snowden, J. A., MSBase Study Group: Comparative Effectiveness of Autologous Hematopoietic Stem Cell Transplant vs Fingolimod, Natalizumab, and Ocrelizumab in Highly Active Relapsing-Remitting Multiple Sclerosis.
JAMA Neurol. 80 (7), 702-713, 2023.
Journal metrics:
D1 Neurology (clinical)
12.
Diouf, I., Malpas, C. B., Sharmin, S., Roos, I., Horakova, D., Kubala Havrdova, E., Patti, F., Shaygannejad, V., Ozakbas, S., Eichau, S., Onofrj, M., Lugaresi, A., Alroughani, R., Prat, A., Duquette, P., Terzi, M., Boz, C., Grand'Maison, F., Sola, P., Ferraro, D., Grammond, P., Yamout, B., Altintas, A., Gerlach, O., Lechner-Scott, J., Bergamaschi, R., Karabudak, R., Iuliano, G., McGuigan, C., Cartechini, E., Hughes, S., Sá, M. J., Solaro, C., Kappos, L., Hodgkinson, S., Slee, M., Granella, F., de Gans, K., McCombe, P., Ampapa, R., Walt, A. v. d., Butzkueven, H., Sanchez-Menoyo, J., Vucic, S., Laureys, G., Sidhom, Y., Gouider, R., Castillo Triviño, T., Gray, O., Aguera-Morales, E., Al-Asmi, A., Shaw, C., Al-Harbi, T., Csépány, T., Sempere, P. A., Trevino-Frenk, I., Stuart, E. A., Kalincik, T.: Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial.
J. Neurol. Neurosurg. Psychiatry. 94 (12), 1004-1011, 2023.
Journal metrics:
D1 Neurology (clinical)
D1 Psychiatry and Mental Health
D1 Surgery
13.
Árokszállási, T., Balogh, E., Orbán-Kálmándi, R. A., Pásztor, M., Árokszállási, A., Nagy, E. B., Belán, I., May, Z., Csépány, T., Csiba, L., Bagoly, Z., Oláh, L.: Elevated Blood Alcohol Concentration Is Associated with Improved Clinical Outcomes of Intravenous Thrombolysis Treatment in Acute Ischemic Stroke Patients: A Retrospective Study.
J Clin Med. 12 (6), 1-13, (article identifier: 2238), 2023.
Journal metrics:
Q1 Medicine (miscellaneous)
14.
Spelman, T., Horakova, D., Ozakbas, S., Alroughani, R., Onofrj, M., Kalincik, T., Prat, A., Terzi, M., Grammond, P., Patti, F., Csépány, T., Boz, C., Lechner-Scott, J., Granella, F., Grand'Maison, F., Walt, A. v. d., Zhu, C., Butzkueven, H., MSBase Study Group: Switching to natalizumab or fingolimod in multiple sclerosis: comparative effectiveness and effect of pre-switch disease activity.
Mult. Scler. Relat. Disord. 70, 1-8, (article identifier: 104477), 2023.
Journal metrics:
Q1 Medicine (miscellaneous)
Q2 Neurology
Q2 Neurology (clinical)
15.
Sharmin, S., Roos, I., Simpson-Yap, S., Malpas, C., Sánchez, M. M., Ozakbas, S., Horakova, D., Havrdova, E., Patti, F., Alroughani, R., Izquierdo, G., Eichau, S., Boz, C., Zakaria, M., Onofrj, M., Lugaresi, A., Weinstock-Guttman, B., Prat, A., Girard, M., Duquette, P., Terzi, M., Amato, M. P., Karabudak, R., Grand'Maison, F., Khoury, S. J., Grammond, P., Lechner-Scott, J., Buzzard, K., Skibina, O., Walt, A. v. d., Butzkueven, H., Turkoglu, R., Altintas, A., Maimone, D., Kermode, A. G., Shalaby, N., Pesch, V. v., Butler, E., Sidhom, Y., Gouider, R., Mrabet, S., Gerlach, O., Soysal, A., Barnett, M., Kuhle, J., Hughes, S., Sá, M. J., Hodgkinson, S., Oreja-Guevara, C., Ampapa, R., Petersen, T., Ramo-Tello, C., Spitaleri, D., McCombe, P., Taylor, B. V., Prevost, J., Foschi, M., Slee, M., McGuigan, C., Laureys, G., Hijfte, L. V., de Gans, K., Solaro, C., Oh, J., Macdonell, R., Aguera-Morales, E., Singhal, B., Gray, O., Garber, J., Wijmeersch, B. V., Mihaela, S., Castillo Triviño, T., Sanchez-Menoyo, J., Khurana, D., Al-Asmi, A., Al-Harbi, T., Deri, N., Fragoso, Y., Lalive, P. H., Sinnige, L. G. F., Shaw, C., Shuey, N., Csépány, T., Sempere, P. A., Moore, F., Decoo, D., Willekens, B., Gobbi, C., Massey, J., Hardy, T. A., Parratt, J., Kalincik, T., the MSBase investigators: The risk of secondary progressive multiple sclerosis is geographically determined but modifiable.
Brain. 146 (11), 4633-4644, 2023.
Journal metrics:
D1 Medicine (miscellaneous)
D1 Neurology (clinical)
16.
Rajda, C., Rózsa, C., Mike, A., Lovas, G., Mezei, Z., Jakab, G., Ács, P., Rum, G., Simó, M., Jobbágy, Z., Bíró, Z., Trauninger, A., Imre, P., Mátyás, K., Deme, I., Illés, Z., Csépány, T.: Treatment of relapsing multiple sclerosis in Hungary: consensus recommendation from the Hungarian neuroimmunology society.
Orphanet J. Rare Dis. 18 (1), 1-8, (article identifier: 183), 2023.
Journal metrics:
Q2 Genetics (clinical)
Q1 Medicine (miscellaneous)
Q1 Pharmacology (medical)
17.
Diouf, I., Malpas, C. B., Sharmin, S., Roos, I., Horakova, D., Havrdova, E., Patti, F., Shaygannejad, V., Ozakbas, S., Izquierdo, G., Eichau, S., Onofrj, M., Lugaresi, A., Alroughani, R., Prat, A., Girard, M., Duquette, P., Terzi, M., Boz, C., Grand'Maison, F., Hamdy, S., Sola, P., Ferraro, D., Grammond, P., Turkoglu, R., Buzzard, K., Skibina, O., Yamout, B., Altintas, A., Gerlach, O., Pesch, V. v., Blanco, Y., Maimone, D., Lechner-Scott, J., Bergamaschi, R., Karabudak, R., Iuliano, G., McGuigan, C., Cartechini, E., Barnett, M., Hughes, S., Sá, M. J., Solaro, C., Kappos, L., Ramo-Tello, C., Cristiano, E., Hodgkinson, S., Spitaleri, D., Soysal, A., Petersen, T., Slee, M., Butler, E., Granella, F., de Gans, K., McCombe, P., Ampapa, R., Wijmeersch, B. V., Walt, A. v. d., Butzkueven, H., Prevost, J., Sinnige, L. G. F., Sanchez-Menoyo, J., Vucic, S., Laureys, G., Van Hijfte, L., Khurana, D., Macdonell, R., Gouider, R., Castillo Triviño, T., Gray, O., Aguera-Morales, E., Al-Asmi, A., Shaw, C., Deri, N., Al-Harbi, T., Fragoso, Y., Csépány, T., Perez Sempere, A., Trevino-Frenk, I., Schepel, J., Moore, F., Kalincik, T.: Variability of the response to immunotherapy among subgroups of patients with multiple sclerosis.
Eur. J. Neurol. 30 (4), 1014-1024, (article identifier: 15706), 2023.
Journal metrics:
Q1 Neurology
Q1 Neurology (clinical)
2022
18.
Sharmin, S., Bovis, F., Malpas, C., Horakova, D., Havrdova, E., Izquierdo, G., Eichau, S., Trojano, M., Prat, A., Girard, M., Duquette, P., Onofrj, M., Lugaresi, A., Grand'Maison, F., Grammond, P., Sola, P., Ferraro, D., Terzi, M., Gerlach, O., Alroughani, R., Boz, C., Shaygannejad, V., Pesch, V. v., Cartechini, E., Kappos, L., Lechner-Scott, J., Bergamaschi, R., Turkoglu, R., Solaro, C., Iuliano, G., Granella, F., Wijmeersch, B. V., Spitaleri, D., Slee, M., McCombe, P., Prevost, J., Ampapa, R., Ozakbas, S., Sanchez-Menoyo, J., Soysal, A., Vucic, S., Petersen, T., de Gans, K., Butler, E., Hodgkinson, S., Sidhom, Y., Gouider, R., Cristiano, E., Castillo Triviño, T., Saladino, M. L., Barnett, M., Moore, F., Rózsa, C., Yamout, B., Skibina, O., Walt, A. v. d., Buzzard, K., Gray, O., Hughes, S., Sempere, P. A., Singhal, B., Fragoso, Y., Shaw, C., Kermode, A. G., Taylor, B. V., Simó, M., Shuey, N., Al-Harbi, T., Macdonell, R., Dominguez, J. A., Csépány, T., Sirbu, C. A., Sormani, M. P., Butzkueven, H., Kalincik, T.: Confirmed disability progression as a marker of permanent disability in multiple sclerosis.
Eur. J. Neurol. 29 (8), 2321-2334, 2022.
Journal metrics:
Q1 Neurology
Q1 Neurology (clinical)
19.
Brouwer, E. D., Becker, T., Moreau, Y., Havrdova, E., Trojano, M., Eichau, S., Ozakbas, S., Onofrj, M., Grammond, P., Kuhle, J., Kappos, L., Sola, P., Cartechini, E., Lechner-Scott, J., Alroughani, R., Gerlach, O., Kalincik, T., Granella, F., Grand'Maison, F., Bergamaschi, R., Sá, M. J., Wijmeersch, B. V., Soysal, A., Sanchez-Menoyo, J., Solaro, C., Boz, C., Iuliano, G., Buzzard, K., Aguera-Morales, E., Terzi, M., Trivio, T. C., Spitaleri, D., Pesch, V. v., Shaygannejad, V., Moore, F., Oreja-Guevara, C., Maimone, D., Gouider, R., Csépány, T., Ramo-Tello, C., Peeters, L.: Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180].
Comput. Meth. Programs Biomed. 213, 1-3, (article identifier: 106479), 2022.
20.
Roos, I., Malpas, C., Leray, E., Casey, R., Horakova, D., Havrdova, E., Debouverie, M., Patti, F., De Seze, J., Izquierdo, G., Eichau, S., Edan, G., Prat, A., Girard, M., Ozakbas, S., Grammond, P., Zephir, H., Ciron, J., Maillart, E., Moreau, T., Amato, M. P., Labauge, P., Alroughani, R., Buzzard, K., Skibina, O., Terzi, M., Laplaud, D., Berger, E., Grand'Maison, F., Lebrun-Frenay, C., Cartechini, E., Boz, C., Lechner-Scott, J., Clavelou, P., Stankoff, B., Prevost, J., Kappos, L., Pelletier, J., Shaygannejad, V., Yamout, B., Khoury, S. J., Gerlach, O., Spitaleri, D. L. A., Pesch, V. v., Gout, O., Turkoglu, R., Heinzlef, O., Thouvenot, E., McCombe, P., Soysal, A., Bourre, B., Slee, M., Castillo Triviño, T., Bakchine, S., Ampapa, R., Butler, E., Wahab, A., Macdonell, R., Aguera-Morales, E., Cabre, P., Ben Nasr, H., Walt, A. v. d., Laureys, G., Van Hijfte, L., Ramo-Tello, C., Maubeuge, N., Hodgkinson, S., Sanchez-Menoyo, J., Barnett, M., Labeyrie, C., Vucic, S., Sidhom, Y., Gouider, R., Csépány, T., Sotoca, J., de Gans, K., Al-Asmi, A., Fragoso, Y., Vukusic, S., Butzkueven, H., Kalincik, T., OFSEP and the MSBase investigators: Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis.
Neurology. 99 (17), e1926-e1944, 2022.
Journal metrics:
D1 Neurology (clinical)
21.
Kokas, Z., Sandi, D., Fricska-Nagy, Z., Füvesi, J., Biernacki, T., Köves, Á., Fazakas, F., Birkás, A. J., Katona, G., Kovács, K., Milanovich, D., Dobos, E., Kapás, I., Jakab, G., Csépány, T., Bense, E., Mátyás, K., Rum, G., Szolnoki, Z., Deme, I., Jobbágy, Z., Kriston, D., Gerócs, Z., Diószeghy, P., Bors, L., Varga, A., Kerényi, L., Molnár, G., Kristóf, P., Nagy, Z. Á., Sátori, M., Imre, P., Péntek, S., Klivényi, P., Kincses, Z. T., Vécsei, L., Bencsik, K.: Do Hungarian multiple sclerosis care units fulfil international criteria?.
PLoS One. 17 (3), 1-15, (article identifier: 0264328), 2022.
Journal metrics:
Q1 Multidisciplinary
22.
Lefort, M., Sharmin, S., Andersen, J. B., Vukusic, S., Casey, R., Debouverie, M., Edan, G., Ciron, J., Ruet, A., De Seze, J., Maillart, E., Zephir, H., Labauge, P., Defer, G., Lebrun-Frenay, C., Moreau, T., Berger, E., Clavelou, P., Pelletier, J., Stankoff, B., Gout, O., Thouvenot, E., Heinzlef, O., Al-Khedr, A., Bourre, B., Casez, O., Cabre, P., Montcuquet, A., Wahab, A., Camdessanche, J. P., Maurousset, A., Ben Nasr, H., Hankiewicz, K., Pottier, C., Maubeuge, N., Dimitri-Boulos, D., Nifle, C., Laplaud, D., Horakova, D., Havrdova, E., Alroughani, R., Izquierdo, G., Eichau, S., Ozakbas, S., Patti, F., Onofrj, M., Lugaresi, A., Terzi, M., Grammond, P., Grand'Maison, F., Yamout, B., Prat, A., Girard, M., Duquette, P., Boz, C., Trojano, M., McCombe, P., Slee, M., Lechner-Scott, J., Turkoglu, R., Sola, P., Ferraro, D., Granella, F., Shaygannejad, V., Prevost, J., Maimone, D., Skibina, O., Buzzard, K., Walt, A. v. d., Karabudak, R., Wijmeersch, B. V., Csépány, T., Spitaleri, D., Vucic, S., Koch-Henriksen, N., Sellebjerg, F. T., Soerensen, P. S., Hilt Christensen, C. C., Rasmussen, P. V., Jensen, M. B., Frederiksen, J. L., Bramow, S., Mathiesen, H. K., Schreiber, K., Butzkueven, H., Magyari, M., Kalincik, T., Leray, E.: Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis.
BMC Med. Res. Methodol. 22 (1), 1-14, (article identifier: 155), 2022.
Journal metrics:
D1 Health Informatics
Q1 Epidemiology
23.
Biernacki, T., Sandi, D., Füvesi, J., Fricska-Nagy, Z., Kincses, Z. T., Ács, P., Rózsa, C., Dobos, E., Cseh, B., Horváth, L., Nagy, Z., Csányi, A., Kovács, K., Csépány, T., Vécsei, L., Bencsik, K., Study investigators: The safety and efficacy of fingolimod: real-world data from a long-term, non-interventional study on the treatment of RRMS patients spanning up to 5 years from Hungary.
PLoS One. 17 (4), 1-21, (article identifier: 0267346), 2022.
Journal metrics:
Q1 Multidisciplinary
2021
24.
Hayden, Z., Bóné, B., Orsi, G., Szots, M., Nagy, F., Csépány, T., Mezei, Z., Rajda, C., Simon, D., Najbauer, J., Illés, Z., Berki, T.: Clinical Characteristics and Outcome of Neuronal Surface Antibody-Mediated Autoimmune Encephalitis Patients in a National Cohort.
Front. Neurol. 12, 1-11, 2021.
Journal metrics:
Q2 Neurology
Q1 Neurology (clinical)
25.
Roos, I., Leray, E., Frascoli, F., Casey, R., Brown, J. W. L., Horakova, D., Havrdova, E., Debouverie, M., Trojano, M., Patti, F., Izquierdo, G., Eichau, S., Edan, G., Prat, A., Girard, M., Duquette, P., Onofrj, M., Lugaresi, A., Grammond, P., Ciron, J., Ruet, A., Ozakbas, S., De Seze, J., Louapre, C., Zephir, H., Sá, M. J., Sola, P., Ferraro, D., Labauge, P., Defer, G., Bergamaschi, R., Lebrun-Frenay, C., Boz, C., Cartechini, E., Moreau, T., Laplaud, D., Lechner-Scott, J., Grand'Maison, F., Gerlach, O., Terzi, M., Granella, F., Alroughani, R., Iuliano, G., Pesch, V. v., Wijmeersch, B. V., Spitaleri, D. L. A., Soysal, A., Berger, E., Prevost, J., Aguera-Morales, E., McCombe, P., Castillo Triviño, T., Clavelou, P., Pelletier, J., Turkoglu, R., Stankoff, B., Gout, O., Thouvenot, E., Heinzlef, O., Sidhom, Y., Gouider, R., Csépány, T., Bourre, B., Al Khedr, A., Casez, O., Cabre, P., Montcuquet, A., Wahab, A., Camdessanche, J. P., Maurousset, A., Patry, I., Hankiewicz, K., Pottier, C., Maubeuge, N., Labeyrie, C., Nifle, C., Coles, A., Malpas, C. B., Vukusic, S., Butzkueven, H., Kalincik, T., MSBase and OFSEP study groups: Determinants of therapeutic lag in multiple sclerosis.
Mult. Scler. 27 (12), 1838-1851, 2021.
Journal metrics:
D1 Neurology
D1 Neurology (clinical)
DEENK University of Debrecen
© 2012 University of Debrecen